COA Measurement Strategy in Modern Oncology Trials

In our October 26 webinar, Signant’s oncology and eCOA science experts shared key considerations for COA measurement strategies in today’s oncology trials and insights from the recent FDA draft guidance regarding the inclusion of patient-reported outcome measures (PROMs). Our presenters also discussed the promise of item banks as well as tips for effective eCOA implementation.

Learn more from the company that has experience across nearly 1,000 oncology trials by tuning in to our webinar recording below.